| Characteristic | Median | Mean |
|---|---|---|
| - | - | - |
| - | - | - |
| - | - | - |
| - | - | - |
| - | - | - |
| - | - | - |
| - | - | - |
| - | - | - |
| - | - | - |
| - | - | - |
The chart is not accessible to screen readers. Please switch to the table view to access the data.
Download
Source
Sources
Release date
March 2020
More information
Region
United States
Survey time period
2009 to 2018
Supplementary notes
* Expected expenditure for new therapeutic agents approved by the Food and Drug Administration (FDA).
Therapeutic areas were obtained
from the anatomical therapeutic
chemical classification system
database. Where agents were not
yet classified, the categorization
was based on the approved
indication.
Citation formats
